1-2 of 2
Ilva Dautaj, MS
Close
Save search
Sort by
Journal Articles

Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Free
Ellen K Ritchie, MD, Rosalind Catchatourian, MD, Rebecca B. Klisovic, MD, Javier Pinilla-Ibarz, MD PhD, Michael W. Deininger, MD PhD, Harry P. Erba, MD PhD, Jerald P. Radich, MD, Michael R. Savona, MD, Ilva Dautaj, MS, Das Purkayastha, Karen Habucky, PhD, Michael J. Mauro, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2875.
https://doi.org/10.1182/blood.V130.Suppl_1.2875.2875
Published: 2017
Journal Articles

ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib

Free
Ellen K. Ritchie, MD, Rose Catchatourian, MD, Rebecca B Klisovic, MD, Javier Pinilla-Ibarz, MD PhD, Michael W. Deininger, MD PhD, Harry P. Erba, MD PhD, Jerald P. Radich, Michael R. Savona, MD, Ilva Dautaj, MS, Johannes Wolff, MD, Michael J. Mauro, MD
Journal: Blood
Blood (2016) 128 (22): 3090.
https://doi.org/10.1182/blood.V128.22.3090.3090
Published: 2016